19 Breast Cancer

452 Breast Cancer

24. Holland R, Conolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited eexcision correlates with prominent residual diseasz in the remainder of the breast. J Clin Onc 1990; 8 : 113-18. 25. Johansson B, Kalsson L, Liljegren G, et al. PDR brachytherapy as the soleadjuvant radiotherapy after breast conserving surgery of T1-T2 breast cancer (abstract) In: Program&Abstracts. 10 th International Brachytherapy Conference Madrid, Nucletron 2000; 127 . 26. Kuske RR, Bolton JS, Mc Kinnon MP, et al. 6.5 - year results of a prospective phase II trial of wide volume brachytherapy as the sole method of breast irradiation in Tis, T1, T2, No1 breast cancer. (abstract) Radiother Oncol 2000; 55 (suppl.1) : 2. 27. Machtay M, Lanciano R, Hoffman J, Hanks G. Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma. Int J Radiat Oncol Biol Phys 1994; 30 : 43- 48. 28. Mangold CA, Rijnders A, Georg D, et al. Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system. Radiotherapy Oncology 2001; 58 : 43-51. 29. Mansfield CM, Komarnicky LT, Schwartz GF, et al. Ten year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 1995; 75 : 2328-36. 30. Mazeron JJ, Simon JM, Crook J, et al. Influence of dose rates on local control of breast carcinoma treated by external beam irradiation plus iridium implant. Int J Radiat Oncol Biol Phys 1991; 21 : 1173-7. 31. Mc Rae D, Rodgers J, Dritschilo A. Dose-volume and complication in interstitial implants for breast carcinoma. Int J Radiat Oncol Biol Phys 1987; 13 : 525-9. 32. Olivotto IA, Rose MA, Osteen RT, et al. Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys 1989; 17 : 747- 53. 33. Perera F, Chisela F, Engel, et al. Method of localisation and implantation of the lumpectomy cavity for high dose rate brachytherapy after conservative surgery for T1 and T2 breast cancer. Int J Radiat Oncol Biol Phys 1995; 31 : 4959-66. 34. Perez CA, Taylor ME, Halverson K, et al. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast; A non-randomized comparison. Int J Radiat Oncol Biol Phys 1996; 34 : 995-1007. 35. Pierquin B, Huart J, Raynal M, et al. Conservative treament for breast cancer: long term results ( 15 years) Radiother Oncol 1991; 20 : 16-23. 36. Polgar C, Major T, Somogyi A, et al. Sole brachytherapy after breast conserving surgery: 4-years results of a pilot study and initial findings of a randomised Phase III trial.(abstract) Radiother Oncol 2000; 55(suppl. 1) : 31. 37. Polgar C, Orosz Z, Fodor J, et al. The effect of high-dose rate brachytherapy and electron boost on local control and side effects after breast conserving surgery: first results of the randomized Budapest breast boost trial (abstract). Radiother Oncol 2001; 60(suppl. 1) : 10-27. 38. Ray GR, Fish VJ. Biopsy and definitive radiation therapy in stage I and II adenocarcinoma of the female breast: analysis of cosmesis and the role of electron beam supplementation. Int J Radiat Oncol Biol Phy s 1983; 9 : 813-18. 39. Recht A, Silver B, Schnitt SJ, et al. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 1985; 11 : 1271-76. 40. Resch A, Pötter R, Van Limbergen E, et al. Long Term Results (10 years) of Intensive Breast Conserving Therapy Including a High Dose and Large Volume Interstitial Brachytherapy Boost (LDR/HDR) for T1/T2-Breast Cancer. Radiother Oncol 2002; 63 (1) , 47-58. 41. Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomised clinical trial in Lyon, France. J Clin Oncol 1997; 15 : 963-68.